healthcare - PitchBook

Healthcare

More news about this topic

Medtech

World’s most valuable surgical robot startup pulls in another $200M

April 2, 2025

CMR Surgical will use the funds to launch its surgical robot in the US

Article

Learn more »
Retail

Sycamore to take Walgreens private in $23.7B deal amid restructuring

March 7, 2025

PE firm Sycamore Partners is acquiring Walgreens for $23.7 billion as the retailer restructures and adapts to rising competition.

Article

Learn more »
Exclusive

Redpoint-led round values longevity startup Function Health at $2.5B

February 19, 2025

The company, co-founded by health influencer Dr. Mark Hyman, is attracting VCs to its promise to personalize lab testing.

Article

Learn more »
AI

These 10 healthcare AI startups have pulled in the most cash

January 17, 2025

The AI healthcare sector has attracted significant investor attention, raising $10.5 billion in VC funding in 2024.

Article

Learn more »
Startups

The maker of health-tracking Oura ring hits $5B valuation

November 19, 2024

Finland-based Oura Health saw its annual sales double this year.

Article

Learn more »
Healthcare

Pharma services dealmaking nears quarterly record

November 18, 2024

PE deal activity in the sector is riding tailwinds from M&A-friendly interest rate policies and GPs’ growing appetite for life sciences investments.

Article

Learn more »
VC Fundraising

Tribe Capital rolls out first $50M healthcare fund

November 18, 2024

The firm’s new strategy comes as healthcare specialist VC firms struggle to fundraise

Article

Learn more »
Featured

Specialty firm scores $4.6B deal in win for healthcare investors seeking exits

November 6, 2024

Webster Equity Partners has secured a hefty exit from a medical practice, finding a strategic buyer and offering a glimmer of hope for investors that have struggled in recent years to offload healthcare-provider assets.

Article

Learn more »
Healthcare

Why PE investors in European healthcare are rolling up their sleeves

October 21, 2024

Fluctuating interest rate changes have put the buy-and-build model under pressure.

Article

Learn more »
Private Equity

Healthcare services takes up half of European healthcare PE deals

October 3, 2024

Clinics and outpatient services saw the highest deal value among healthcare sub-sectors

Article

Learn more »
Healthcare

Affinity agrees to $658M carveout of Australia’s Lumus Imaging

September 23, 2024

Australian PE is on pace to see slower dealmaking than last year

Article

Learn more »
Private Equity

Is MENA’s private equity market losing momentum?

September 11, 2024

Private equity in MENA got off to a slow start in 2024. But some sectors, including healthcare, are attracting a bigger share of the region’s investments.

Article

Learn more »
Biopharma

Candid Therapeutics launches with $370M and a pair of acquisitions

September 9, 2024

The startup focuses on repurposing cancer treatments for hard-to-treat autoimmune disorders.

Article

Learn more »
Buyouts

Are healthcare PE funds losing their advantage?

September 5, 2024

Healthcare specialist funds of recent vintages performed on par with PE funds investing in other strategies.

Article

Learn more »
Top Investor

Biotech’s top 10 most active VC investors

September 4, 2024

The nascent application of AI in biotech and drug discovery is helping fuel a surge in valuations of venture-backed biopharma startups.

Article

Learn more »
Healthcare

PE deals in European healthcare near $10B in 2024

August 19, 2024

Investment in European healthcare services is picking up again. Does this mean recovery for the sector?

Article

Learn more »
Biotech

Hot biotech stocks have LPs eyeing hybrid venture vehicles

July 16, 2024

In an interview with PitchBook, Stephanie Sirota, RTW Ventures’ chief business officer, says that the veteran venture capitalist’s outlook on biotech has never been brighter—but it takes money to make money.

Article

Learn more »
Private Equity

More pharma services deals expected to emerge from incubation

July 12, 2024

PE managers are building a pipeline of deals within the pharma services sector as the healthcare provider category falls out of favor

Article

Learn more »